In an observational study published in the previous issue of Critical Care, Elseviers and colleagues [1] report that the mortality of critically ill patients treated with renal replacement therapy (RRT) for acute kidney injury (AKI) is much higher than that of those treated by a conservative strategy (that is, without RRT). RRT remains an independent factor associated with a higher mortality after adjustments for acute disease severity (risk ratio [RR] 1.73, 95% confi dence interval [CI] 1.4 to 2.2) based on the Stuivenberg Hospital Acute Renal Failure (SHARF) score as well as other corrections for usually wellestablished prognostic factors (age, sex, Sequential Organ Failure Assessment [SOFA] score, type of AKI, delayed admission, and clinical conditions). Th is observation might have two alternative explanations: fi rst, RRT per se could worsen the prognosis of acutely ill patients experiencing AKI; second, AKI of patients treated by RRT was more severe and this greater severity is not fully refl ected by the severity scores and adjustment factors used in the multivariable models of the study. In fact, the role of AKI, as an independent factor for mortality, is currently well documented, regardless of the severity of AKI [2, 3] . Th e subpopulation requiring RRT in the intensive care unit represents the more severe population, and the need for RRT appears to be an independent risk factor for death [4] . However, the need for renal supportive care is nonetheless a marker of severity. Th e specifi c role of RRT was fi rst proposed by Guerin and colleagues [5] in their French epidemiological study. Indeed, they reported, in a multi ple logistic regression analysis, that the absence of hemo dialysis in their severe AKI population (serum creatinine [sCr] of greater than 300 μmol/L, urine output of less than 500 mL/24 hours, or the need for hemo dialysis) was a signifi cant predictor of survival (odds ratio 1.78, 95% CI 1.05 to 3.04; P 0.032). Th is fi nding is of paramount importance given the current trend to initiate RRT early in the course of AKI. Moreover, recent epidemiological [6] or prospective controlled [7] studies show that the main criteria for RRT initiation are based on low urine output prior to a marked increase in sCr or serum urea level. RRT remains associated with a high mortality, and given the lack of survival improvement using continuous RRT [8] or augmented delivered dose [7, 9] , early initia tion of RRT might be promising. Actually, numerous retrospective studies report a better outcome with earlier initiation, but confl icting results are reported by other studies [10] . Finally, a recent meta-analysis [11] shows a barely signifi cant decrease in mor tality using early initiation of RRT in prospective studies (RR 0.64, 95% CI 0.40 to 1.05; P <0.08) and a signifi cant decrease in mortality using early initiation of RRT in observational studies (RR 0.72, 95% CI 0.64 to 0.82; P <0.001). Th is new strategy seems attractive, but regarding the lack of strong data in favor of any benefi cial eff ect, we should pay heed to the potential adverse eff ects. Unfortunately, the study by Elseviers and colleagues [1] presents many shortcomings, which hamper any defi nitive conclusion. First, the study is an observational trial and no pre specifi ed criteria regarding RRT indications and the timing of initiation were provided in the diff erent centers. Th is shortcoming may explain the heterogeneity in the rate of patients treated with RRT between the diff erent centers and the associated mortality. Second, adjustment criteria did not take into account specifi c AKI characteristics, like oliguria, or specifi c prognostic scores based on metabolic
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